Beam Therapeutics (BEAM) Other Non-Current Assets (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Other Non-Current Assets data on file, last reported at $7.8 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $7.8 million, up 17.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (up 17.35% YoY), and the FY2025 annual result was $634000.0, down 92.22% from the prior year.
• Other Non-Current Assets advanced to $7.8 million in Q1 2026 per BEAM's latest filing, from $634000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $15.4 million in Q2 2023 and troughed at $634000.0 in Q4 2025.
• A 5-year average of $8.4 million and a median of $8.1 million in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets increased 20.99% in 2023, then tumbled 92.22% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $12.8 million in 2022, then tumbled by 31.64% to $8.7 million in 2023, then fell by 6.59% to $8.1 million in 2024, then plunged by 92.22% to $634000.0 in 2025, then jumped by 1123.5% to $7.8 million in 2026.
• Business Quant data shows BEAM's Other Non-Current Assets at $7.8 million in Q1 2026, $634000.0 in Q4 2025, and $6.7 million in Q3 2025.